Toggle light / dark theme

A study led by Umeå University, Sweden, presents new insights into how stem cells develop and transition into specialized cells. The discovery can provide increased understanding of how cells divide and grow uncontrollably so that cancer develops.

“The discovery opens a new track for future research into developing new and more effective treatments for certain cancers,” says Francesca Aguilo, associate professor at the Department of Molecular Biology at Umeå University and leader of the study in collaboration with various institutions including the University of Pavia, University of Texas Health Science Center at Houston, Universidad de Extremadura, and others.

All cells in the body arise from a single fertilized egg. From this single origin, various specialized cells with widely differing tasks evolve through a process called cellular differentiation. Although all cells share the same origin and share the same genetic information, specialized cells use the information in different ways to perform different functions. This process is regulated by genetic and epigenetic mechanisms.

Researchers tracked the health of nearly one thousand mice on a variety of diets to see if these diets would extend the mice’s lifespan. The study was designed to ensure that each mouse was genetically distinct, which allowed the team to better represent the genetic diversity of the human population. By doing so, the results are made more clinically relevant, elevating the study to one of the most significant investigations into aging and lifespan to date.

For nearly a century, laboratory studies have shown consistent results: eat less food, or eat less often, and an animal will live longer. But scientists have struggled to understand why these kinds of restrictive diets work to extend lifespan, and how to best implement them in humans. Now, in a long-awaited study to appear in the Oct. 9 issue of Nature, scientists at The Jackson Laboratory (JAX) and collaborators tracked the health of nearly one thousand mice on a variety of diets to make new inroads into these questions.

The study was designed to ensure that each mouse was genetically distinct, which allowed the team to better represent the genetic diversity of the human population. By doing so, the results are made more clinically relevant, elevating the study to one of the most significant investigations into aging and lifespan to date.

Imagine doctors being able to predict how a disease might progress in your body based on your genetic makeup, or which treatments would be most effective for you.

This research could bring us one step closer to that reality.

To sum it all up, this new research is shaking up how we think about evolution. Instead of seeing it as a series of random events, the study suggests there’s a level of predictability influenced by gene families and genetic history.

Bioengineers propose “electro-agriculture,” a method that replaces photosynthesis with a solar-powered reaction converting CO2 into acetate, potentially reducing U.S. agricultural land needs by 94% and supporting controlled indoor farming.

Initial experiments focus on genetically modified acetate-consuming plants like tomatoes and lettuce, with potential future applications in space agriculture.

Revolutionary Electro-Agriculture

Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis—a potentially lethal stiffening of tissue that, once begun, is irreversible. For many patients, a liver transplant is their only hope. However, research at Cedars-Sinai in Los Angeles may offer patients a glimmer of hope. Scientists there say they’ve successfully reversed liver fibrosis in mice.

Reporting in the journal Nature Communications, the team say they’ve discovered a genetic pathway that, if blocked, might bring fibrosis to a halt.

The three genes involved in this fibrotic process are called FOXM1, MAT2A and MAT2B.

Discovery advances development of new therapeutic options for cancer and other diseases. A research team led by the University of California, Irvine has engineered an efficient new enzyme that can produce a synthetic genetic material called threose nucleic acid. The ability to synthesize artificial chains of TNA, which is inherently more stable than DNA, advances the discovery of potentially more powerful, precise therapeutic options to treat cancer and autoimmune, metabolic and infectious diseases.

A paper recently published in Nature Catalysis describes how the team created an enzyme called 10–92 that achieves faithful and fast TNA synthesis, overcoming key challenges in previous enzyme design strategies.

Inching ever closer to the capability of natural DNA synthesis, the 10–92 TNA polymerase facilitates the development of future TNA drugs.

This level of precision could be a game-changer for therapies that require gene expression in one specific tissue, without impacting others.

By providing more control over where and when genes are activated, these AI-designed CREs could potentially be used in a variety of therapeutic applications, from treating genetic diseases to optimizing tissue regeneration.

As this AI-powered approach to designing CREs matures, the possibilities are vast. Beyond basic research, these synthetic DNA switches could be employed in biomanufacturing or to develop advanced treatments for a range of conditions, offering more effective ways to manipulate genes with unprecedented precision.

The acetate would then be used to feed plants that are grown hydroponically. The method could also be used to grow other food-producing organisms, since acetate is naturally used by mushrooms, yeast, and algae.

“The whole point of this new process to try to boost the efficiency of photosynthesis,” says senior author Feng Jiao, an electrochemist at Washington University in St. Louis. “Right now, we are at about 4% efficiency, which is already four times higher than for photosynthesis, and because everything is more efficient with this method, the CO2 footprint associated with the production of food becomes much smaller.”

To genetically engineer acetate-eating plants, the researchers are taking advantage of a metabolic pathway that germinating plants use to break down food stored in their seeds. This pathway is switched off once plants become capable of photosynthesis, but switching it back on would enable them to use acetate as a source of energy and carbon.